Full-Time
Biotechnology for cell and gene therapies
No salary listed
Senior, Expert
Pittsburgh, PA, USA
Supporting the execution of the buildout project in Pittsburgh, PA.
ElevateBio focuses on biotechnology, specifically in the cell and gene therapy market. They use proprietary technologies like gene editing and induced pluripotent stem cells (iPSC) to develop and manufacture therapies for various clients, including biotech companies and healthcare providers. Their unique approach combines discovery, development, manufacturing, and commercialization, which helps streamline processes and promote scientific advancements. The goal of ElevateBio is to advance cell and gene therapy by overcoming barriers to innovation and delivering effective treatments.
Company Size
501-1,000
Company Stage
Series D
Total Funding
$1.2B
Headquarters
Waltham, Massachusetts
Founded
2017
Help us improve and share your feedback! Did you find this helpful?
Flexible Work Hours
ElevateBio announces presentations at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting.
ElevateBio appoints David Hallal to Executive Chairman of the Board of Directors.
ElevateBio has partnered with Amazon Web Services (AWS) to expedite the discovery and development of gene editing therapeutics using generative AI (genAI).
"ComEd is proud to work hand in hand with partners like Elevate and Bickerdike to deliver innovative, clean energy technologies to communities that need them most.
In addition, Michael Paglia, Chief Technology Officer at ElevateBio's BaseCamp(R), has joined Xcellbio's Scientific Advisory Board.